home / stock / tffp / tffp news


TFFP News and Press, TFF Pharmaceuticals Inc - Ordinary Shares From 04/17/20

Stock Information

Company Name: TFF Pharmaceuticals Inc - Ordinary Shares
Stock Symbol: TFFP
Market: NASDAQ
Website: tffpharma.com

Menu

TFFP TFFP Quote TFFP Short TFFP News TFFP Articles TFFP Message Board
Get TFFP Alerts

News, Short Squeeze, Breakout and More Instantly...

TFFP - TFF Pharmaceuticals to Present at April 2020 Virtual Investor Summit

Corporate presentation and live webcast scheduled for April 22, 2020 at 10:00am ET TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) tech...

TFFP - APHA, AAL among premarket gainers

Applied DNA Sciences (NASDAQ: APDN ) +61%  on advancement of COVID-19 vaccine candidates. More news on: Applied DNA Sciences, Inc., Comstock Holding Companies, Inc., BOQI International Medical Inc., Stocks on the move, , Read more ...

TFFP - TFF Pharma up 21% premarket on technology deal

TFF Pharmaceuticals (NASDAQ: TFFP ) has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). More news on: TFF Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read mor...

TFFP - TFF Pharmaceuticals Announces Cooperative Research and Development Agreement (CRADA) with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) for use of its Thin Film Freezing Technology Platform

USAMRIID to study use of TFF technology to formulate dry powder neutralizing antibodies and vaccines against national priority biodefense threats for pulmonary delivery TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commer...

TFFP - TFF Pharmaceuticals Announces R&D Collaboration with the University of Georgia for a Universal Influenza Vaccine

Study to evaluate the Company’s Thin Film Freezing technology to formulate dry powder universal influenza vaccines for pulmonary delivery TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative dru...

TFFP - TFF Pharmaceuticals, Inc. 2019 Q4 - Results - Earnings Call Presentation

The following slide deck was published by TFF Pharmaceuticals, Inc. in conjunction with their 2019 Q4 earnings Read more ...

TFFP - TFF Pharmaceuticals reports Q4 results

TFF Pharmaceuticals (NASDAQ: TFFP ): Q4 GAAP EPS of -$2.00. More news on: TFF Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

TFFP - TFF Pharmaceuticals Reports Fourth Quarter Results and Full Year 2019 Financial and Business Results

Conference call and live webcast scheduled for Thursday, March 26, 2020 at 4:30pm EDT TFF Pharmaceuticals, Inc. (NASDAQ:TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) te...

TFFP - TFF Pharmaceuticals Reschedules Fourth Quarter and Full-Year 2019 Financial and Business Results Conference Call for March 26, 2020 to 4:30 PM (EDT)

Conference call and live webcast was previously scheduled for 8:30 AM (EDT) TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology ...

TFFP - TFF Pharmaceuticals to Hold Fourth Quarter and Full-Year 2019 Financial and Business Results Conference Call on March 26, 2020

Company to hold conference call and webcast at 8:30 AM EDT TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today a...

Previous 10 Next 10